PLRX vs ZION · $77.3M cap vs P/E 11, rev $354.0M
Pliant Therapeutics Inc (PLRX) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
PLRX currently screens at market cap $77.3M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the PLRX and ZION stock pages for the full models.
Not investment advice.